Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 370-374

  Tré Hardy, Marie ^a   Traore, Hamidou ^b   El Manssouri, Naïma ^a   Vanderbist, Francis ^b   Vaneechoutte, Mario ^c   Devleeschouwer, Michel Jean ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cystic fibrosis; Mature biofilm; Pseudomonas aeruginosa; Synergistic activity; Treatment simulation

Indexed keywords

CLARITHROMYCIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG POTENTIATION; GENOTYPE; IN VITRO STUDY; MONOTHERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIMULATION;

ANTI-BACTERIAL AGENTS; BIOFILMS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GENOTYPE; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SPUTUM; TIME FACTORS; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 67651218977     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.04.010     Document Type: Article

References (15)

1. Staab D. Cystic fibrosis-therapeutic challenge in cystic fibrosis children. Eur J Endocrinol 151 Suppl. 1 (2004) S77-80
2. Hatch R.A., and Schiller N.L. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 42 (1998) 974-977
3. Tré-Hardy M., Mace C., El Manssouri N., Vanderbist F., Traore H., and Devleeschouwer M.J. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. Int J Antimicrob Agents 33 (2009) 40-45
4. Brimicombe R.W., Dijkshoorn L., van der Reijden T.J., Kardoes I., Pitt T.L., van den Broek P.J., et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 7 (2008) 30-36
5. Romling U., Wingender J., Muller H., and Tummler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60 (1994) 1734-1738
6. Fothergill J.L., Upton A.L., Pitt T.L., Hart C.A., and Winstanley C. Diagnostic multiplex PCR assay for the identification of the Liverpool Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa. J Cyst Fibros 7 (2008) 258-261
7. Van Daele S.G., Franckx H., Verhelst R., Schelstraete P., Haerynck F., Van Simaey L., et al. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J 25 (2005) 474-481
8. Frederiksen B., Koch C., and Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23 (1997) 330-335
9. Tre-Hardy M., Vanderbist F., Traore H., and Devleeschouwer M.J. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int J Antimicrob Agents 31 (2008) 329-336
10. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340 (1999) 23-30
11. Pilcer G., Sebti T., and Amighi K. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation. Pharm Res 23 (2006) 931-940
12. Wagner V.E., and Iglewski B.H. P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 35 (2008) 124-134
13. Gordon C.A., Hodges N.A., and Marriott C. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 22 (1988) 667-674
14. Mitsuya Y., Kawai S., and Kobayashi H. Influence of macrolides on guanosine diphospho-d-mannose dehydrogenase activity in Pseudomonas biofilm. J Infect Chemother 6 (2000) 45-50
15. Kondoh K., Hashiba M., and Baba S. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol Suppl 525 (1996) 56-60